Astrazeneca Vaccine Supply Continues News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(3)
LONDON (dpa-AFX) - Today s Daily Dose brings you news about Applied Genetic s Achromatopsia trial results; the deadlock in AstraZeneca vaccine supply in EU; partnership of Lilly, Vir Biotech and GlaxoSmithKline in fighting COVID-19; and ZymeWork s progress with ZW49 study.
Read on.
1. Applied Genetic Throws Light on Achromatopsia Trials
Applied Genetic Technologies Corp. s (AGTC) phase I/II clinical trials evaluating AAV gene therapy product candidates in patients with achromatopsia caused by CNGB3 or CNGA3 mutations, dubbed ACHMB3 and ACHMA3 trials, have provided for the first time quantitative evidence of improvements in visual sensitivity.
Achromatopsia (ACHM) is an inherited condition caused by mutations in one of several genes, with the two most common being mutations in either the CNGB3 or CNGA3 genes. ....

South Korea , United Kingdom , City Of , Stella Kyriakides , Eli Lilly , Geert Kersten , Vir Biotechnology Inc , Zymeworks Inc , Genetic Technologies Corp , European Commission , Aikido Pharma Inc , Rubius Therapeutics Inc , Sorrento Therapeutics Inc , Petmed Express Inc , Life Sciences Inc , Daily Dose , Applied Genetic , Vir Biotech , Genetic Throws Light , Genetic Technologies , Astrazeneca Vaccine Supply Continues , European Commissioner , Food Safety , Trial Data , Biotech Continues To Rally , Vir Biotechnology ,